scholarly journals Insulin-Like Growth Factor Promotes Engraftment, Differentiation, and Functional Improvement after Transfer of Embryonic Stem Cells for Myocardial Restoration

Stem Cells ◽  
2004 ◽  
Vol 22 (7) ◽  
pp. 1239-1245 ◽  
Author(s):  
Theo Kofidis ◽  
Jorg L. de Bruin ◽  
Toshiyuki Yamane ◽  
Leora B. Balsam ◽  
Darren R. Lebl ◽  
...  
Keyword(s):  
Stem Cells ◽  
Embryonic Stem Cells ◽  
Growth Factor ◽  
Embryonic Stem ◽  
Functional Improvement ◽  
Insulin Like Growth Factor

Quiescent Status of Very Small Embryonic Like Stem Cells (VSELs) Points to Pivotal Role of Autocrine Role of Insulin-Like Growth Factor-2 (Igf2) – Ras-Activating Guanine Nucleotide Exchange Factor (Rasgrf1) Axis in Regulating Proliferation of Embryonic Stem Cells.

Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 1484-1484
Author(s):  
Izabela Klich ◽  
Maciek Tarnowski ◽  
Dong-Myung Shin ◽  
Janina Ratajczak ◽  
Magdalena Kucia ◽  
...  
Keyword(s):  
Stem Cells ◽  
Embryonic Stem Cells ◽  
Growth Factor ◽  
Conflicts Of Interest ◽  
Embryonic Stem ◽  
Surface Glycoprotein ◽  
Imprinted Genes ◽  
Insulin Like Growth Factor ◽  
Epigenetic Changes

Abstract Abstract 1484 Poster Board I-507 The proper balance in expression of so-called imprinted genes is crucial for initiation of embryogenesis. Overall, there are ∼80 imprinted genes (expressed either from maternal or paternal chromosomes only), for which proper mono-allelic expression regulates totipotential status of the zygote and pluripotency of developmentally early stem cells. Of these 80 genes, only three (Igf2-H19, Rasgrf1, Meg3) are paternally methylated. We reported that the population of pluripotent VSELs deposited in adult organs (Leukemia 2006:20;857) is kept in quiescent status by erasure/demethylation of the paternal imprint on Igf2-H19 and Rasgrf1 loci and hypermethylation of the maternally imprinted Igf2R locus (Leukemia 2009, in press). Because of these epigenetic changes, VSELs do not express Igf2 or Rasgrf1, but overexpress non-signaling Igf2 receptor (Igf2R). It is known that while Igf2 is signaling through two tyrosine kinase receptors, i.e., insulin receptor (InsR) and insulin-like growth factor-1 receptor (Igf1R), Igf2R is a non-signaling surface glycoprotein that acts as a molecular sink to prevent binding of Igf2 to InsR or Igf1R. This suggests that Igf2 is an autocrine regulator of the early steps of embryogenesis. In addition, because VSELs do not express Igf2 but overexpress Igf2R, this causes a decrease in Igf2 signaling in these cells and explains their quiescence. Based on these observations, we hypothesized that the Igf2-Igf1R/InsR-Rasgrf1 axis is crucial for proliferation of the earliest embryonic stem cells. In fact, we found that Igf2, Insulin, Igf1R, InsR, and Igf2R are expressed in the established murine embryonic ES-D3 cell line. Moreover, ES-D3 cells express another Igf1R ligand, insulin-like growth factor-1 (Igf1). We also noticed that expression of Igf2 as well as Rasgrf1, but not Ins, Igf1, Igf1R, or InsR, is selectively and highly upregulated (∼100 times and ∼15 times, respectively) in cells isolated from rapidly expanding (for three days) ES-D3-derived embryonic bodies. More importantly, our Western blot data revealed that activated/phosphorylated Rasgrf1 is upregulated in ES-D3 cells after stimulation by Igf2, Igf1, and Insulin, suggesting this protein is involved in InsR and Igf1R signaling. To address this issue, we knocked down Rasgrf1 and Igf2 expression in ES-D3 cells employing an shRNA strategy. As such, downregulation of Rasgrf1 (by ∼80%) produced ES-D3 cells with significantly impaired proliferation that displayed profound defects in embryonic body growth in a hanging drop model as well as in leukemia inhibitory factor-depleted cultures. Furthermore, we found that Rasgrf1-/− cells lost chemotactic responsiveness to all insulin factors. In contrast, knock down of Igf2 did not produce a significant phenotype, most likely because of redundancy or compensation by Igf1 and Ins. Conclusions. For the first time, our data provide novel evidence that insulin factors secreted by early embryonic cells are crucial for their proliferation/expansion and that Rasgrf1 is an important protein involved in signaling from activated Igf1R and InsR. The Igf2 - Igf1R/InsR - Rasgrf1 axis plays a crucial role in the proliferation of embryonic stem cells and is required for embryoid body formation. However, autocrine-secreted Igf1 and Ins could replace Igf2. Rasgrf1 seems to be an obligatory molecule to maintain proper signaling from InsR and Igf1R. Perturbation of these pathways by epigenetic changes in somatic-imprinted genes explains the quiescence of VSELs deposited in adult tissues. On the other hand, positive modulation of this axis is crucial for developing more powerful strategies to “unleash the power” of these cells and employ them in regenerative medicine. Disclosures: No relevant conflicts of interest to declare.

Developmentally regulated use of alternative promoters creates a novel platelet-derived growth factor receptor transcript in mouse teratocarcinoma and embryonic stem cells

1989 ◽  
Vol 9 (10) ◽  
pp. 4563-4567
Author(s):  
T H Vu ◽  
G R Martin ◽  
P Lee ◽  
D Mark ◽  
A Wang ◽  
...  
Keyword(s):  
Stem Cells ◽  
Stem Cell ◽  
Embryonic Stem Cells ◽  
Growth Factor ◽  
Short Form ◽  
Embryonic Stem ◽  
Growth Factor Receptor ◽  
Extracellular Domain ◽  
Platelet Derived Growth Factor ◽  
Alternative Promoters

Embryonal carcinoma and embryonic stem cells expressed a novel form of platelet-derived growth factor receptor mRNA which was approximately 1,100 base pairs shorter than the 5.3-kilobase (kb) transcript expressed in fibroblasts and other cell types. The 4.2-kb stem cell transcript was initiated within the genomic region immediately upstream of exon 6 of the 5.3-kb transcript and therefore lacked the first five exons, which encode much of the extracellular domain of the receptor expressed in fibroblasts. In stem cells, the short form was predominant, although both forms were present at low levels. Following differentiation in vitro, expression levels of the long form increased dramatically. These findings suggest that during early embryogenesis, a stem cell-specific promoter is used in a stage- and cell type-specific manner to express a form of the platelet-derived growth factor receptor that lacks much of the extracellular domain and may function independently of ligand.

Sign in / Sign up

Export Citation Format

Share Document